Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells
Authors
Keywords
-
Journal
Proteomics Clinical Applications
Volume 8, Issue 11-12, Pages 924-931
Publisher
Wiley
Online
2014-08-05
DOI
10.1002/prca.201400058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress
- (2013) Lucia Biasutto et al. EXPERIMENTAL CELL RESEARCH
- Pathology of Gastric Cancer and Its Precursor Lesions
- (2013) Evgeny Yakirevich et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Molecular Pathogenesis of Gastric Cancer
- (2013) Ceu Figueiredo et al. HELICOBACTER
- Detrimental Effect of Class-selective Histone Deacetylase Inhibitors during Tissue Regeneration following Hindlimb Ischemia
- (2013) Francesco Spallotta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDAC4 Governs a Transcriptional Program Essential for Synaptic Plasticity and Memory
- (2012) Richard Sando et al. CELL
- MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors
- (2012) Wajana L. Labisso et al. CELL CYCLE
- Beside the MEF2 axis: Unconventional functions of HDAC4
- (2012) Andrea Clocchiatti et al. CELLULAR SIGNALLING
- Aurora B-dependent Regulation of Class IIa Histone Deacetylases by Mitotic Nuclear Localization Signal Phosphorylation
- (2012) Amanda J. Guise et al. MOLECULAR & CELLULAR PROTEOMICS
- HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
- (2011) E. A. Stronach et al. CANCER RESEARCH
- HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
- (2011) Hao Geng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibitors of Histone Deacetylases
- (2011) Kelly Huber et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer
- (2010) Kathrin Mutze et al. ANNALS OF SURGICAL ONCOLOGY
- Reverse phase protein microarrays advance to use in clinical trials
- (2010) Claudius Mueller et al. Molecular Oncology
- A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer
- (2010) Yen-An Tang et al. PLoS One
- Histone Deacetylase Inhibitors
- (2009) Xujun Ma et al. DRUGS
- Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes
- (2009) Angela Nebbioso et al. EMBO REPORTS
- Docetaxel: its role in current and future treatments for advanced gastric cancer
- (2009) Masahiko Nishiyama et al. Gastric Cancer
- A phosphorylation-acetylation switch regulates STAT1 signaling
- (2009) O. H. Kramer et al. GENES & DEVELOPMENT
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
- Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer
- (2008) Amy J. VanMeter et al. MOLECULAR & CELLULAR PROTEOMICS
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- MYC and gastric adenocarcinoma carcinogenesis
- (2008) Danielle Queiroz Calcagno et al. WORLD JOURNAL OF GASTROENTEROLOGY
- PP2A Regulates HDAC4 Nuclear Import
- (2007) Gabriela Paroni et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started